This site may receive compensation from the provider linked above. Full disclosure.
Weight loss and GLP-1 providers currently serving Berrien County, Georgia — sourced from Google Business listings.
Wellness center
4530 N Valdosta Rd, Valdosta, GA 31602
Weight loss service
1205 Baytree Rd # 3, Valdosta, GA 31602
Weight loss service
2517 Bemiss Rd F, Valdosta, GA 31602
Business listings sourced from Google Maps. Information may not be current.
Berrien County is a county in Georgia with a population of approximately 19,397 residents. Our telehealth platform connects patients across all communities in Berrien County with board-certified physicians who can prescribe FDA-approved GLP-1 medications online. Georgia has 159 counties — more than any state east of the Mississippi — with many rural counties in South Georgia facing severe healthcare deserts. Atlanta metro exploded in population, creating huge demand for convenient telehealth options.
GLP-1 receptor agonists — including semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound®) — are clinically proven weight loss medications. Georgia's obesity rate of 33.7% places it among the top 15 states. Rural Southwest Georgia counties (Dougherty, Lee, Terrell) have obesity rates exceeding 40%. Patients in Berrien County can now access these treatments through a simple online consultation, without the need to travel to an in-person clinic.
Access Ozempic, Wegovy, Mounjaro, and Zepbound — all FDA-approved GLP-1 medications proven to support significant weight loss in clinical trials.
All prescribing physicians in our network hold active Georgia medical licenses. Consultations comply with Georgia telehealth law (Georgia Code § 43-34-8).
Our simple 3-step process makes getting a GLP-1 prescription easy for Berrien County residents.
GLP-1 telehealth services are available across all Georgia counties. Browse neighboring counties below.
Explore GLP-1 telehealth availability across Georgia's major cities.
Yes. Georgia law permits telehealth prescriptions for GLP-1 medications after a proper clinical evaluation under Georgia Code § 43-34-8. Our network of Georgia-licensed physicians can complete your consultation online and send a prescription to your preferred pharmacy in Berrien County or arrange home delivery.
Patients in Berrien County can be prescribed semaglutide (Ozempic®, Wegovy®), tirzepatide (Mounjaro®, Zepbound®), and liraglutide (Saxenda®) — all FDA-approved GLP-1 receptor agonists indicated for weight management. Your physician will recommend the most appropriate option based on your health profile.
Consultation fees vary by provider, typically ranging from $0 to $199 for the initial visit. Medication costs depend on insurance coverage, manufacturer savings programs, and pharmacy choice. Many patients in Georgia qualify for significant savings through patient assistance programs.
After completing your online health assessment, most patients in Berrien County receive a physician response within 24–48 hours. If approved, your prescription can be sent to a pharmacy near you in Berrien County or shipped directly to your home within 2–5 business days.
Berrien County has several local weight loss clinics and medical practices that may offer GLP-1 treatments in person. However, our telehealth service provides the same quality of care from the convenience of your home, with licensed Georgia physicians available to patients throughout Berrien County.
Connect with experienced, US-licensed physicians specializing in metabolic health and GLP-1 therapy. All providers are board-certified and committed to evidence-based care.
Medically reviewed by
Dr. Sarah Mitchell, MD, ABOM
Board-Certified in Obesity Medicine • Last reviewed: June 5, 2026
Black Box Warning: In rodent studies, semaglutide and tirzepatide caused thyroid C-cell tumors. It is unknown whether GLP-1 receptor agonists cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans. These medications are contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Common side effects may include nausea, vomiting, diarrhea, constipation, abdominal pain, headache, and injection site reactions. These typically diminish as dosage is gradually escalated.
Serious side effects may include pancreatitis, gallbladder problems, kidney injury, hypoglycemia (with insulin), and allergic reactions. Consult your healthcare provider immediately if you experience severe symptoms.
Contraindications: History of medullary thyroid carcinoma, MEN 2, pancreatitis, pregnancy or breastfeeding, severe gastrointestinal disease. This is not a complete list — always discuss your full medical history with your physician.
Clinical References:
